Literatura científica selecionada sobre o tema "Télésurveillance des dispositifs médicaux"
Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos
Índice
Consulte a lista de atuais artigos, livros, teses, anais de congressos e outras fontes científicas relevantes para o tema "Télésurveillance des dispositifs médicaux".
Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.
Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.
Artigos de revistas sobre o assunto "Télésurveillance des dispositifs médicaux"
Desire, Amélie, e Charlotte Gourio. "Dispositifs médicaux". Actualités Pharmaceutiques Hospitalières 3, n.º 12 (dezembro de 2007): 42–48. http://dx.doi.org/10.1016/s1769-7344(07)70019-7.
Texto completo da fonteRuault, Céline, e Charlotte Gourio. "Dispositifs médicaux". Actualités Pharmaceutiques Hospitalières 5, n.º 17 (fevereiro de 2009): 38. http://dx.doi.org/10.1016/s1769-7344(09)70135-0.
Texto completo da fonteCerbelaud, Nadège, e Charlotte Gourio. "Dispositifs médicaux". Actualités Pharmaceutiques Hospitalières 5, n.º 17 (fevereiro de 2009): 39–40. http://dx.doi.org/10.1016/s1769-7344(09)70136-2.
Texto completo da fonteBrischoux, Sonia. "Dispositifs médicaux". Actualités Pharmaceutiques Hospitalières 5, n.º 17 (fevereiro de 2009): 41–42. http://dx.doi.org/10.1016/s1769-7344(09)70137-4.
Texto completo da fonteCrickx, B., e X. Arrault. "Dispositifs médicaux implantables". Annales de Dermatologie et de Vénéréologie 135, n.º 1 (janeiro de 2008): 66–69. http://dx.doi.org/10.1016/s0151-9638(08)70214-x.
Texto completo da fonteLetard, J. C. "Les dispositifs médicaux". Acta Endoscopica 33, n.º 2 (abril de 2003): 269–71. http://dx.doi.org/10.1007/bf03028419.
Texto completo da fonteHajjar, Joseph. "Traitement des dispositifs médicaux". Le Praticien en Anesthésie Réanimation 9, n.º 6 (dezembro de 2005): 482–87. http://dx.doi.org/10.1016/s1279-7960(05)83775-1.
Texto completo da fonteTétart, Florence. "Dispositifs médicaux et allergies". Dermato Mag 11, n.º 3 (1 de junho de 2023): 181–83. http://dx.doi.org/10.1684/dmg.2023.644.
Texto completo da fonteSommer, Johanna, e Martine Bideau. "Dispositifs médicaux moins polluants". Revue Médicale Suisse 20, n.º 877 (2024): 1125. http://dx.doi.org/10.53738/revmed.2024.20.877.1125.
Texto completo da fonteAncellin, Joël. "La sécurité des dispositifs médicaux". RBM-News 17, n.º 4 (janeiro de 1995): M5. http://dx.doi.org/10.1016/s0222-0776(00)88939-7.
Texto completo da fonteTeses / dissertações sobre o assunto "Télésurveillance des dispositifs médicaux"
Chehbani, Amel. "Etude et mise en œuvre d’un système communicant sans fil et sans radio pour la mesure de paramètres physiologiques des nouveau-nés". Electronic Thesis or Diss., Limoges, 2024. http://www.theses.fr/2024LIMO0009.
Texto completo da fonteThe weak immune systems in the elderly, newborns and preterm infants increase their susceptibility to cardiovascular disease and heart failure. Indeed, symptoms of cardiac pathology can be quite unusual and sporadic in this population. This requires continuous monitoring of cardiac activity by electrocardiogram (ECG), which enables early detection of abnormalities. Conventionally, ECG systems are wired, limiting continuous monitoring and patient comfort. Thanks to technology, portable and wireless ECG systems have also been developed, based mainly on efficient radio frequency (RF) technologies, which enable these users to be monitored regularly. However, security and privacy requirements, interference generation, potential harmful effects on patient health, spectrum congestion and energy efficiency are challenges for the massive deployment of RF technologies in healthcare scenarios. Instead of relying on the limitations of RF systems, this thesis focuses on an alternative solution based on optical wireless technologies that enable safe and environmentally-friendly communications. This solution consists of a monitoring system using an infrared link between a transmitter embedded in an ECG sensor placed on the user's body and receivers placed on the ceiling of the environment. In order to study the three monitoring contexts, the corresponding optical channel was simulated using a ray-tracing technique combined with the numerical Monte-Carlo method. Considering the specificities of the monitoring scenario, the population (age and mobility) and the modeled environment (transparent material of premature baby incubators), the static gain characterizing the channel was obtained. This gain was used in a chain developed to simulate ECG transmission in each context. The reliability of the proposed remote monitoring system is thus conditioned by the quality of the transmitted ECG signal. This has been assessed at application level using the Signal Quality Index (SQI) method, which consists in extracting spectral and statistical characteristics from the ECG. In addition, given its usefulness in monitoring the development of premature infants, heart rate variability (HRV) has also been analyzed by computing the temporal parameters that characterize RR intervals in an ECG. The main objective is to assess the impact of time-varying optical transmission performance on the quality of the received ECG signal, in order to design a less intrusive, reliable and cost-effective system for remote ECG signal monitoring. SQIs consist in extracting spectral and statistical characteristics from the ECG. In addition, given its usefulness in monitoring the development of premature infants, heart rate variability (HRV) was also analyzed by computing the temporal parameters that characterize RR intervals. The main objective is to assess the impact of optical transmission performance on ECG quality metrics. For this purpose, a general analysis approach was implemented to jointly study the evolution of (SQIs) and VFC temporal parameters at the application level as a function of classical metrics at the physical level, namely (SNR) and (BER). The results of this research showed the potential of using wireless optics in such medical contexts to provide a reliable and energy-efficient solution. Indeed, in all three cases investigated, ECG signals of sufficient quality for reliable diagnoses were obtained at moderate levels of transmitted optical power, which is important for a portable medical remote monitoring system
Leroy, Sylvie. "Traçabilité informatique des dispositifs médicaux implantables : création du logiciel "VIGIPHARM R version dispositifs médicaux"". Paris 5, 1997. http://www.theses.fr/1997PA05P199.
Texto completo da fonteHuot, Laure. "Evaluation clinique des dispositifs médicaux". Phd thesis, Université Claude Bernard - Lyon I, 2012. http://tel.archives-ouvertes.fr/tel-00983482.
Texto completo da fonteNeveu, David. "La normalisation des dispositifs médicaux". Bordeaux 2, 1997. http://www.theses.fr/1997BOR2P105.
Texto completo da fonteLe, Moual Sylvie. "Assurance qualité des dispositifs médicaux". Paris 5, 1992. http://www.theses.fr/1992PA05P248.
Texto completo da fonteAbed, Aïcha. "Nouveaux dispositifs médicaux à base d'hydrogels de polysaccharides". Paris 13, 2012. http://www.theses.fr/2012PA132062.
Texto completo da fonteThis work describes the development of new medical devices based on hydrogel of polysaccharides (pullulan and dextran). In recent years, our laboratory was interested in the biological properties of synthetic or natural polysaccharides and their interactions with endogenous growth factors and matrix components. So we had the idea to apply their properties to the design of a hybrid material composed of a polypropylene mesh coated with polysaccharides hydrogel. The first objective of this work is to improve the integration of materials currently used in clinical by using of hybrid prosthesis and understand the properties of these hydrogels in vitro and in vivo. In the second part of this work, based on the hydrogel properties a new system of storage and transport of tissue at room temperature was developed while limiting mechanical shocks and contamination associated with leaking fluids. Taking as a model of rat arteries, we validated this system in vitro and in vivo. Finally, we developed a new system for cryopreservation of cells and tissues. This hydrogel based polysaccharides reduces the quantities of toxic cryoprotectants agents during freezing. This method was validated in vitro and in vivo and in comparison with the reference procedure
Lamarche, Juliette. "Les dispositifs médicaux non réutilisables de circulation extra-corporelle". Paris 5, 1997. http://www.theses.fr/1997PA05P148.
Texto completo da fonteMaho, Thomas. "Stérilisation de dispositifs médicaux ensachés par plasmas froids basse pression". Thesis, Orléans, 2016. http://www.theses.fr/2016ORLE2077.
Texto completo da fonteStandard sterilization methods such as autoclave, ethylene oxide or irradiation can affect the biocompatibility of medical devices, especially those sensitive to heat or chemicals products. Numerous studies have demonstrated the possibility to use low pressure plasmas as an alternative sterilization process: low process temperature, treatment time competitive to autoclave and without any toxic agent. However, the sterile state preservation is still a problem. In the framework of the ANR PLAS'STER project, this CIFRE thesis focus on a new sterilization process development based on low pressure cold plasmas. The innovation resides in the creation and the confinement of a plasma inside a sterilization bag, thereby ensuring the conservation of the sterile state. The first part was dedicated to the physical characterization of the plasmas discharges confined inside the bag of sterilization. Secondly, the bactericidal efficiency of the process was demonstrated on Gram negative and Gram positive bacteria according to the EN556 standard. Additional tests on E. coli lead to hypothesis on the sterilization mechanisms and opened tracks on the optimization of our process. Finally, the properties analysis of biomaterials demonstrated the absence of macromolecular modifications and validated the potentiality of the process PLAS' STER as the sterilization method alternative
Ethgen, Bonnet Morgane. "Méthodes d'évaluation des traitements non pharmacologiques : l'exemple des dispositifs médicaux implantables". Paris 6, 2012. http://www.theses.fr/2012PA066184.
Texto completo da fonteOur first study was to compare the reporting f harm in trials of pharmacologic (PT) and nonpharmacologic treatment (NPT). 193 articles were analysed. After adjustement for medical areas, sample size, funding source, and multicenter trails, data on harm were more often described in PT reports than in NPT reports in reporting dverse events. The lack of reporting harm in trials assessing NPT in rheuatic disease is an important barrier to evaluating the benefit-harm balance of NPT. Our second work evaluated the harm reporting and the quality of internal and external validity in published reports evaluating the stent for percutaneous coronary intervention. 132 articles were analyzed. The volume of interventions per center was described in 2 reports, and in 5 reports for operator expertise. The generation of allocation sequence was adequate in 58. 3%, treatment allocation was concealed in 34. 8%. Several harm related data were not adequately accounted for in articles and the current reprting of results of RCTs testing stents needs to be improved to allow readers to appraise the risk of biais and the applicability of results
Folefack, Ernest. "Recherches sur le droit international des médicaments et des dispositifs médicaux". Bordeaux 4, 1998. http://www.theses.fr/1998BOR40034.
Texto completo da fonteThe objective of the author is prouve the existence of international law rules regulating the movement of drugs and medical devices in the international market. These rules are mainly produced by international organisations with competence on health either on the universal basis (see who) or regional basis (eu or the european council). Thesis rules have strong links with technical regulation such as standard. Theses rules have public health purposes since they are aimed at maintaining the quality of drugs and medical devices as regard safety of patients. They are imposed at all stages of the production of drugs from the conception (international and national pharmacopoeia, glp), the stage of manufacturing (gmp) the respect of legal and ethical rules concerning the testing of new drugs on human being (gcp), the harmonisation of new drugs registration procedures, the rational use of drugs and medical devices based on adequates information, restriction of publicity and an overrall worldwide monitoring of the use of drugs and medical devices. But a global international legal coherent system of regulation of drugs and medical devices is yet to be consolidated
Livros sobre o assunto "Télésurveillance des dispositifs médicaux"
normalisation, Association française de. Stérilisation des dispositifs médicaux. Saint-Denis La Plaine: AFNOR, 2004.
Encontre o texto completo da fonteWorld Health Organization (WHO). Dons de dispositifs médicaux: Considérations relatives à leur demande et à leur attribution. Switzerland: World Health Organization, 2012.
Encontre o texto completo da fonteLaval, Guillemette. Soins palliatifs: Les principales thérapeutiques en soins palliatifs chez l'adulte et la personne âgée : médicaments, dispositifs médicaux, prescriptions de sortie. 3a ed. Montpellier: Sauramps médical, 2006.
Encontre o texto completo da fonteStérilisation des dispositifs médicaux. Paris: AFNOR, 1999.
Encontre o texto completo da fonteWorld Health Organization (WHO). Package Série Technique de l'OMS Sur les Dispositifs Médicaux. World Health Organization, 2012.
Encontre o texto completo da fonteWorld Health Organization (WHO). Liste interinstitutions de dispositifs médicaux prioritaires pour des interventions essentielles: En santé reproductive, maternelle, néonatale et infantile. World Health Organization, 2017.
Encontre o texto completo da fonteMABANZA, Tryphon. Incidents Critiques d'une Machine d'anesthÉsie Clinique Hier et AUJOURD'HUI: Une Introduction Aux Normes des Dispositifs Médicaux et des Stratégies Efficaces Pour Son Contrôle d'assurance Qualité Quotidien et Régulier. Independently Published, 2021.
Encontre o texto completo da fonteCapítulos de livros sobre o assunto "Télésurveillance des dispositifs médicaux"
Gaillard, C., A. Capelle e X. Armoiry. "Dispositifs médicaux en oncologie". In Pharmacie Clinique Pratique en Oncologie, 82–94. Elsevier, 2020. http://dx.doi.org/10.1016/b978-2-294-76375-5.00010-5.
Texto completo da fonteCallanquin, J., C. Camuzeaux e P. Labrude. "Dispositifs Médicaux et Matériovigilance". In Le matériel de maintien à domicile, 15–32. Elsevier, 2008. http://dx.doi.org/10.1016/b978-2-294-08853-7.50002-2.
Texto completo da fonteGaillard, Claire, e Daniel Hartmann. "Biocompatibilité des dispositifs médicaux". In Pharmacie clinique et dispositifs médicaux, 51–55. Elsevier, 2023. http://dx.doi.org/10.1016/b978-2-294-77399-0.00008-9.
Texto completo da fonteGhislain, Jean-Claude. "Approche réglementaire des dispositifs médicaux". In Pharmacie clinique et dispositifs médicaux, 13–16. Elsevier, 2023. http://dx.doi.org/10.1016/b978-2-294-77399-0.00002-8.
Texto completo da fonteCabelguenne, Delphine, Pierre Cassier, El-Mahdi Hafiani, Vincent Létoublon, Marie Selvy e Valérie Sautou. "Dispositifs médicaux et développement durable". In Pharmacie clinique et dispositifs médicaux, 91–96. Elsevier, 2023. http://dx.doi.org/10.1016/b978-2-294-77399-0.00014-4.
Texto completo da fonteSalomez-Ihl, Cordélia, Rémy Collomp, Alexandre Moreau-Gaudry e Pierrick Bedouch. "e-santé et dispositifs médicaux". In Pharmacie clinique et dispositifs médicaux, 327–41. Elsevier, 2023. http://dx.doi.org/10.1016/b978-2-294-77399-0.00036-3.
Texto completo da fonteGaillard, Claire, Daniel Hartmann e Yves François. "Les dispositifs médicaux en stomathérapie". In Pharmacie clinique et dispositifs médicaux, 233–38. Elsevier, 2023. http://dx.doi.org/10.1016/b978-2-294-77399-0.00026-0.
Texto completo da fonteChambrin, Pierre-Yves, e Gilles Aulagner. "Évaluation clinique des dispositifs médicaux". In Pharmacie clinique et dispositifs médicaux, 17–20. Elsevier, 2023. http://dx.doi.org/10.1016/b978-2-294-77399-0.00003-x.
Texto completo da fonteGoeury, Dominique, Gilles Aulagner, Olivier Claris e Frédérique Perlier. "Le retraitement des dispositifs médicaux à usage unique". In Pharmacie clinique et dispositifs médicaux, 79–84. Elsevier, 2023. http://dx.doi.org/10.1016/b978-2-294-77399-0.00012-0.
Texto completo da fonteCabelguenne, Delphine, Damien Royané, Vincent Piriou e Stéphanie Genay. "Principes de la perfusion médicamenteuse et dispositifs médicaux utilisés en perfusion intraveineuse". In Pharmacie clinique et dispositifs médicaux, 99–111. Elsevier, 2023. http://dx.doi.org/10.1016/b978-2-294-77399-0.00015-6.
Texto completo da fonteTrabalhos de conferências sobre o assunto "Télésurveillance des dispositifs médicaux"
Danet, C., V. Duhalde, A. Culetto, K. Barange, L. Buscail, C. Barrué, I. Labadens e P. Cestac. "Comment informer les professionnels de santé sur les Dispositifs Médicaux? Création en endoscopie digestive d'un outil pilote informatique connecté au livret des Dispositifs Médicaux de l'hôpital". In Journées Francophones d'Hépato-Gastroentérologie et d'Oncologie Digestive (JFHOD). Georg Thieme Verlag KG, 2019. http://dx.doi.org/10.1055/s-0039-1680970.
Texto completo da fonte